earnings
confidence high
sentiment neutral
materiality 0.80
Henry Schein Q4 non-GAAP EPS $1.21 beats year-ago $1.07; guides FY23 $5.25-$5.42
HENRY SCHEIN INC
2022-FY EPS reported
$3.91
revenue$12,647,000,000
- Q4 net sales $3.4B, +1.2% as reported; internal sales ex-PPE/COVID test kits +5.0% in local currencies.
- GAAP diluted EPS $0.34 (incl. $121M restructuring, $34M impairment) vs $1.05 prior year; non-GAAP $1.21 vs $1.07.
- Full-year 2022 non-GAAP EPS $4.81, up from $4.51; FY23 guidance $5.25-$5.42, excluding amortization.
- Board authorized additional $400M stock repurchase; Q4 bought ~3.6M shares for $285M at avg $79.55.
- Expects FY23 sales growth ~1-3%, PPE/COVID test kit sales to decline ~30-35%; operating margin ~10-15 bps below 2022.